tag:blogger.com,1999:blog-68639032169616677912024-03-19T02:24:26.744-07:00sovipzoneAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.comBlogger503125tag:blogger.com,1999:blog-6863903216961667791.post-19020679578196978082012-11-09T05:50:00.001-08:002012-11-09T05:50:13.383-08:00Loans - LWWFast Loans for Bad Credit
Poor credit can happen to anyone. It isn't a crime! These plans have fantastic aspect involving no credit assessment that offers a chance to involve Fast Loans For Bad Credit. Cash advance loans hold little greater rates of interest because they are short-run anyway. Yet a good researching the market will help you to area reduced charge offer quickly. This may demand Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com19tag:blogger.com,1999:blog-6863903216961667791.post-51339790672828696052012-08-26T12:19:00.001-07:002012-08-26T12:21:19.015-07:00Social Media MarketingSocial media marketing occurs when a business runs on the social media, for example Facebook, Twitter or YouTube, to gain site visitors or attention. The objective of this form of marketing is usually to encourage website visitors to discuss info derived using social network. The message spreads coming from consumer to be able to user, obtaining the very same influence since old fashioned word ofAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com11tag:blogger.com,1999:blog-6863903216961667791.post-46815144153167699902012-08-23T15:15:00.000-07:002012-08-26T12:34:56.937-07:00The Blog Ate My Job!I just received this comment via my "Contact Us" form:"John, while the information you post online is informative and I am glad someone is bring (sic) things to public attention it is also can be estremely (sic) opnionated (sic) and unjust. Please realize that the actions you take in your writing can and has cost people their jobs. I work for an ad agency. I try my best to ensure my contributionsAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com3tag:blogger.com,1999:blog-6863903216961667791.post-85413086934895711082012-08-23T06:27:00.000-07:002012-08-26T12:34:56.955-07:00Retro Relpax Web Site Features Woman Mopping the Floor. Inspirational? Not!The "DDR on DTC" column in the August 2012 issue of MM&M magazine ripped into a print ad that showed a woman migraine sufferer being able to mop the floor after taking the Pfizer anti-migraine headache drug Replax."DTC ads used to be over-aspirational," said the author, Deborah Dick-Rath, "we saw relieved arthritis sufferers running marathons or playing Frisbee. With Relpax, the insight Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com8tag:blogger.com,1999:blog-6863903216961667791.post-72693910227719656812012-08-22T08:50:00.000-07:002012-08-26T12:34:56.981-07:00Lipitor U.S. Sales Tank 70% in 2012 vs 2011!According to Drugs.com, Lipitor U.S. sales in Q2 of 2012 were only 30% of what they were in Q2 2011 ($579 million vs. $1,949 million, respectively (see chart below; Source: http://www.drugs.com/stats/lipitor).Meanwhile, sales of Crestor (a competitor anti-cholesterol drug) increased only somewhat during the same period (see chart below; Source: http://www.drugs.com/stats/crestor).I concludeAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com3tag:blogger.com,1999:blog-6863903216961667791.post-85574318081004168892012-08-20T07:27:00.000-07:002012-08-26T12:34:57.043-07:00Certifying Prescription Grade Smartphone Medical AppsAn article in yesterday's NYT focused on what I call "Prescription Grade Smartphone Medical Apps." The article said the idea of such apps "excites some people in the health care industry, who see them as a starting point for even more sophisticated applications that might otherwise never be built" (read the article here)."But unlike a 99-cent game, apps dealing directly with medical care cannot Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com3tag:blogger.com,1999:blog-6863903216961667791.post-8342272288174085782012-08-19T14:18:00.001-07:002012-08-19T14:18:09.160-07:00sovipzonesovipzoneAnonymousnoreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-81505337593141511452012-08-18T08:58:00.000-07:002012-08-26T12:34:57.056-07:00Public's Confidence in Science Remains Steady Over 38 Years, But Not So for MedicineMichael Ritchie, Postdoctoral Fellow at Pfizer, recently posted to the Think Science Blog that he was NOT surprised that the American public "lost significant trust in the institutions of education, the executive branch of the federal government, organized religion, congress, banks/financial institutions and the press" over the period from 1973 through 2010. He cited results of a study conducted Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com1tag:blogger.com,1999:blog-6863903216961667791.post-72837219921807463182012-08-17T07:44:00.000-07:002012-08-26T12:34:57.073-07:00The $400 Million bapi Drug Failure: Are Patient Advocates the Scapegoat?"Few people in pharma or the investment community were surprised at bapineuzumab's failure, as most odds makers put its chances for success at approximately 25 percent," said Daniel R. Hoffman, Ph.D., in a post to the Philadelphia Inquirer Check Up blog (see "Choosing between baldfaced political lies and Pharma's half-truths").Bapineuzumab is an experimental drug for the treatment of Alzheimer's Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-24970016438353596562012-08-15T13:47:00.000-07:002012-08-26T12:34:57.094-07:00Lilly Overtakes Pfizer as Biggest DTC Advertising Spender!According to cegedim Strategic Data, Lilly overtook Pfizer in total direct-to-consumer (DTC) spending in April, 2012. The chart below shows the top 10 DTC spenders between July 2011 and April 2012.Pfizer spent nearly $900 million in DTC advertising in 2011. $220 million of that was for Lipitor. I predicted that Lipitor would hold the "Key to DTC Ad Spending in 2012" (see here) and this chartAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-89327092070205250052012-08-15T12:41:00.000-07:002012-08-26T12:34:57.112-07:00Fake vs. Real Pharma Twitter FollowersPiotr Wrzosinski (@pwrzosin), IPM Digital Marketing at Roche and a member of my Pharma Twitter Pioneer Group (see here), recently posted this to Twitter today:"0% of my followers are fake. How many fake followers do you have..? http://sttsp.pl/ahaf @StatusPeople #FollowerSpam"Goodie! Another social media metric I can use to compare pharma Twitter accounts. I quickly followed the link to Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-10834816064668596782012-08-15T07:12:00.000-07:002012-08-26T12:34:57.137-07:00How Johnson & Johnson Uses Twitter for Patient Support: A-plus for Effort, D-minus for SharingEvery day, I get a synopsis of tweets and newsfeeds from selected pharma companies that I am following (see "News Direct from the Pharma Industry"). Lately, I've been noticing a number of tweets from Johnson and Johnson (@JNJComm) that are direct responses to complaints from consumers about its products. In some cases, complainants have had an extended conversation with JNJ.However, you won't Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-21854009556207872862012-08-13T10:33:00.000-07:002012-08-26T12:34:57.165-07:00New Pharma Business Model: Prizes, Not Patents, for Innovative DrugsA BMJ articled titled "Pharmaceutical research and development: what do we get for all that money?" was roundly criticized by Rich Meyer of World of DTC Marketing blog and Derek Lowe of In the Pipeline blog. Both have both ripped into the central premise of the BMJ article; specifically critiquing these statements made by the authors: (1) the "widely touted innovation crisis in pharmaceuticals isAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-51993656895090688942012-08-10T08:38:00.000-07:002012-08-26T12:34:57.256-07:00Who's Your Social Media Daddy? A Panel DiscussionThat is one of the questions/topics to be discussed by a panel of experts I will be moderating at the next PharmaForce conference in Princeton, NJ, on October 30, 2012. Actually, the real question to be considered is "Who Owns Your Social Media Initiatives?"Pharma Marketing News is a Media Partner for this event and is helping promote it through advertising. The panel I volunteered to moderate isAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-35402179007608507142012-08-08T05:12:00.000-07:002012-08-26T12:34:57.357-07:00Is Type 2 Diabetes Drug Marketing Responsible for Misdiagnosis of Type 1 Diabetics?A Wall Street Journal article documents several cases of people being misdiagnosed by general practitioners as having Type 2 diabetes when they actually have Type 1 diabetes, "a substantially different condition" (see "Wrong Call: The Trouble Diagnosing Diabetes"). According to the article:"An incorrect diagnosis usually occurs in the offices of primary-care doctors, many of whom haven't receivedAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-81733094006123631232012-08-07T04:42:00.000-07:002012-08-26T12:34:57.455-07:00Pfizer and Janssen Halt Alzheimer Drug Development: Why Not Try Gamification?"In the wake of another negative trial with the anti-amyloid biologic drug bapineuzumab, Pfizer and Janssen said they were halting development of the product for mild to moderate Alzheimer's disease," reports medpage today (here).Pfizer may have had high hopes for this drug because it already launched a multichannel marketing/PR campaign centered around "getting old" (see "Pfizer's Social Media Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com1tag:blogger.com,1999:blog-6863903216961667791.post-43683466768545854012012-08-06T13:45:00.000-07:002012-08-26T12:34:57.557-07:00Cure by Gamification: Science or Wishful Thinking?Last week, I wrote about a video game -- Akili, meaning "wisdom" in Swahili -- that the developers plan to submit to the FDA for approval in the hope that "clinicians will turn to before prescribing medicines for ADHD" (see "The Next New Drug: An FDA-Approved Video Game")."We would aim to have efficacy and tolerability that outstrips any of the drugs," said Dr. Martucci, an associate at PureTech Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com1tag:blogger.com,1999:blog-6863903216961667791.post-20418846759211086252012-08-04T05:30:00.000-07:002012-08-26T12:34:57.660-07:00Does Generic Competition Stifle Branded Pharma Innovation?Sure, use of generic drugs saves payers -- U.S. Gov't, insurances companies, and patients -- money. But does generic competition harm the innovation of new and improved drugs?According to a report published by the Generic Pharmaceutical Association (GPhA), the answer is no. Let's look at some of the data.First, the GPha claims that generic prescription drugs in the U.S. saved about $193 billion Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-64374807742157173872012-08-03T08:03:00.000-07:002012-08-26T12:34:57.752-07:00Paula Deen and Other Proof that Monetary Rewards Improve AdherenceLast month it was reported that celebrity chef and paid spokesperson for Novo Nordisk had lost 30 pounds in the six months since she signed on to help promote Novo's diabetes drug, Victoza (see "Paula Deen Loses 30 lbs. Urges Twitter Fans to Pig Out on Fourth of July!"). This was good for Deen and redemption for Novo Nordisk, which was criticized by me and others for choosing Deen -- who is Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-2009495490281958542012-08-03T04:54:00.000-07:002012-08-26T12:34:57.845-07:00Phil Disclosure: Mickelson is a Serial Undisclosed Celebrity EndorserToday, while reading an article about 5 Guys Burgers ("All in the Family") in the August 2012 issue of Forbes Magazine, I came across a reference to Phil Mickelson. In 2010, Mickelson gave a glowing, unprompted endorsement of Five Guys Burgers during a press conference at The Players Championship."What I’ve done the last five days, go to Five Guys Burgers. That place is so good. I can’t stop Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-42329186713463648612012-08-02T12:08:00.000-07:002012-08-26T12:34:57.948-07:00The U.S. Pharma Industry Recession (or Depression?) ContinuesIs the Pharma Industry in a Recession?YesNoNot sureNot yet, but soonMaybe not, but it's hurting! Last week, while at a New Jersey networking event, I met many people who used to be employed in the pharmaceutical industry but who are now "in transition," which is one of those "Awkward Euphemisms" for out of work and looking for a job (see "Days of Live Pharma Reps are Numbered: M&A's and Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-76897335262532061602012-07-31T05:17:00.000-07:002012-08-26T12:34:58.051-07:00The Next New Drug: An FDA-Approved Video GameImagine my surprise when I read this in today's Wall Street Journal: "Akili Interactive Labs Inc. of Boston, formed by start-up-creating firm PureTech Ventures, and San Francisco company Brain Plasticity Inc. are seeking Food and Drug Administration approval for a video game treatment they hope clinicians will turn to before prescribing medicines for ADHD" (read the story here).I've been writing Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-59307730062583503682012-07-30T10:51:00.000-07:002012-08-26T12:34:58.160-07:00Pharma Support of CME at Lowest Level Ever Recorded!According to data maintained by the Accreditation Council for Continuing Medical Information (ACCME), in 2011 the percent of accredited CME revenue attributed to the pharmaceutical/medical device industry (i.e., grants, advertising, and exhibit fees) was 33.2% of total revenue received from all sources.This is the lowest percentage attributed to commercial sources since ACCME began reporting Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-82965142156132871742012-07-27T06:35:00.000-07:002012-08-26T12:34:58.265-07:00War on Counterfeit/Illegal Drugs Hobbled by Same Demons as Real WarPfizer Intelligence Uncovers $200 of Counterfeit Viagra In Manila Raid!"Armed with a tip from pharmaceutical company Pfizer Inc., several dozen government investigators carried out a series of rapid fire raids one day last month on what were supposed to be the key suppliers of counterfeit drugs in the city [Manila]," reports the Wall Street Journal (read the story here)."The net result of the Anonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0tag:blogger.com,1999:blog-6863903216961667791.post-47133008716946037092012-07-25T05:05:00.000-07:002012-08-26T12:34:58.357-07:00Days of Live Pharma Reps are Numbered: M&A's and Outsourcing - the "Bain/Bane" of the U.S. Pharma IndustryLast night, my sons and I attended a NJ BioPharma Networking Group (NJBPNG) meetup at the Princeton Sports Bar and Grille. NJBPNG is an ad hoc LikedIn group, which you can join (here).This group is mostly comprised of senior pharmaceutical executives in the research side of the drug industry (click on infographic on the right for more NJBPNG demographics).It was a good night out with my sons, butAnonymoushttp://www.blogger.com/profile/03051201257281703412noreply@blogger.com0